SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
28 hedge funds and large institutions have $375M invested in Sinovac Biotech, Ltd in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+25
Holders Change %
+833.33%
% of All Funds
0.38%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
26
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $334M | – | – | – |
|
|
VC
2
Vivo Capital
Palo Alto,
California
| $38.2M | +$38.2M | +5,903,000 | New |
|
|
NAH
3
Neumann Advisory (HK)
Central,
Hong Kong
| $2.04M | – | – | – |
|
4
Renaissance Technologies
New York
| $849K | +$849K | +1,312,520 | New |
|
5
Wells Fargo
San Francisco,
California
| $109K | +$109K | +16,851 | New |
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $106K | +$106K | +16,430 | New |
|
7
Morgan Stanley
New York
| $54K | +$54K | +8,344 | New |
|
8
UBS Group
Zurich,
Switzerland
| $14.3K | +$14.3K | +2,213 | New |
|
|
HI
9
Horizon Investments
Charlotte,
North Carolina
| $336 | +$336 | +52 | New |
|